by Jerome Puginier | Oct 20, 2022 | News
An update and indications on future directions are available in the very interesting paper* from Antea DeMarsilis just published in Metabolism It presents each class of agents by: ✔️mechanism of action✔️details of administration ✔️side effect profile✔️...
by Jerome Puginier | Oct 18, 2022 | News
biotech, pharma, medtech and lifescience Companies rely on us to develop their international market presence and access new b2b markets in switzerland and in the european union. From the market access strategy to the local operations, direct or through a network of...
by Jerome Puginier | Mar 9, 2021 | News
Proteomics allows a better understanding of the physiopathology of alzheimersdisease This statement is suggested and supported by: an amazing and comprehensive paper(1) by Sruti Rayaprolu et al. from Emory University school of medicine in Atlanta explains how and why...
by Jerome Puginier | Feb 14, 2021 | News
Even though nobody’s publishing epidemiological and mortality data every day CKD, Marta Ruiz-Ortega et al from Universidad Autónoma de Madrid reminds us in an interesting paper that this condition is progressing as a consequence of (besides the...
by Jerome Puginier | Feb 1, 2021 | News
Today’s a great Day for us, a great Day for Life Science, a great Day for the thousands of people working for Moderna and a great Day for him, Stéphane Bancel. FDA has issued an emergency use authorization for Moderna’s COVID 19 vaccine, few days after the Pfizer...
